The Dec. 8 Board of Zoning Appeals hearing to determine if Acadia Healthcare would be granted a special variance to relocate its Indianapolis Methadone Comprehensive Treatment Center to Southgate Plaza was cancelled because there were not enough board members present to reach a quorum.
The hearing has been rescheduled for 1 p.m. Tuesday, Jan. 5, in the Public Assembly Room of the City-County Building.
Many Southsiders are opposed to the clinic, 2626 E. 46th St., moving to 3820 Madison Ave.
Most prevalent among those apprehensions are an increased crime rate for the area, added traffic, a lack of parking and the fact that such a center does nothing to improve the neighborhood’s image, which the University of Indianapolis, civic groups, businesses and residents have put so much effort into doing.
If the board grants Acadia a special use, it will spend about $2 million to renovate the building.
The outpatient center specializes in the treatment of opioid dependence. The facility staffs a medical director who examines and evaluates all patients, nurses and counselors. The center, which has outgrown its building, offers education and awareness programs.